"The EAC remains the most diverse and interactive antibody meeting”

Advisory Board

Christian Klein, Head of Oncology Programmes, Roche Pharmaceutical Research and Early DevelopmentChristian Klein
Head of Oncology Programmes
Roche Pharmaceutical Research and Early Development

Hans-Peter Gerber, CSO and President, Maverick TherapeuticsHans-Peter Gerber
CSO and President
Maverick Therapeutics

Ahuva Nissim, Reader, Antibody and Therapeutic Engineering, Queen Mary University of LondonAhuva Nissim
Reader, Antibody and Therapeutic Engineering
Queen Mary University of London

Alain Beck, Senior Director, NBEs Analytical Chemistry, Pierre Fabre, Associate Editor, mAbsAlain Beck
Senior Director, NBEs Analytical Chemistry, Pierre Fabre; Associate Editor, mAbs

Ulrich Brinkmann, Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Centre MunichUlrich Brinkmann
Scientific Director, Roche Pharma Research & Early Development
Roche Innovation Centre Munich

Ezio Bonvini, SVP & CSO, Research, Macrogenics Ezio Bonvini
SVP & CSO, Research
Macrogenics 

John Delaney, Executive Director, Amgen Biologics Discovery John Delaney
Executive Director
Amgen Biologics Discovery 

Christian Rommel, Global Head of Oncology Discovery, RocheChristian Rommel
Global Head of Oncology Discovery
Roche

Janice Reichert, Executive Director, The Antibody Society; Editor-in-Chief, mABs Janice Reichert
Executive Director, The Antibody Society; Editor-in-Chief, mABs

Michael DeRidder, Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, Neuroscience, and ADD, GSKMichael DeRidder
Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, Neuroscience, and ADD
GSK

Peter Senter, VP, Distinguished Research Fellow, Seattle GeneticsPeter Senter
VP, Distinguished Research Fellow
Seattle Genetics

800+ Attendees | 300+ Speakers | 600+ 1-2-1 Meetings

Sign Up for Event Updates

Congress Topics

Protein engineering & R&D

  • Engineering antibody formats
  • Display of biologics
  • Antibody screening and analytics

Bispecific Discovery

  • Bispecific combinations
  • New technology and armed bispecifics

Armed antibody development

  • ADCs and armed antibodies in preclinical and clinical development

AI in antibody discovery

  • AI and image analytics to develop new uses for pre-existing antibodies

Platform technology showcase

  • Antibody characterisation
  • Antibody manufacture

Bispecifics development

  • Bispecific preclinical and clinical development
  • Case studies and trials

mAbs

  • Updates on mAb discovery and development
  • Antibody engineering and optimising expression

Armed antibodies discovery

  • ADC and loaded antibodies
  • Payload discovery
  • Linker technology

Novel targets and biomarker discovery

  • Early stage biomarker discovery
  • Target development
  • New biomarker development

New technological advancements

  • Optimising expression and purification technologies
  • New screening and analytical technologies

Investment and regulation

  • Investor panel
  • Regulatory updates
  • Antibody naming

Co-located with 

World Biosimilar congress

World Immunotherapy Congress

HPAPI World Congress

Part of

Festival of Biologics

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sponsors & Exhibitors

 

  • Gold Sponsor

    MabDesign at European Antibody Congress

    Exhibitor

    MUNIT at European Antibody Congress

    Associate Sponsor

    Lonza at European Antibody Congress
  • Associate Sponsor

    Food Pharma Systems at European Antibody Congress

    Gold Sponsor

    Retrogenix at European Antibody Congress

    Gold Sponsor

    Fujifilm Diosynth Biotechnologies U.S.A., Inc. at European Antibody Congress
  • Silver Sponsor

    Sartorius Stedim Biotech U.K. at European Antibody Congress

    Silver Sponsor

    ACRO Biosystems Inc at European Antibody Congress

    Silver Sponsor

    MaxCyte at European Antibody Congress
  • Silver Sponsor

    Isogenica Ltd at European Antibody Congress

    Associate Sponsor

    Abzena at European Antibody Congress

    Associate Sponsor

    Bioreclamationivt at European Antibody Congress
  • Associate Sponsor

    AbCheck at European Antibody Congress

    Partner

    Canton of Basel-Stadt at European Antibody Congress

    Exhibitor

    MInakem High Potent at European Antibody Congress
  • Exhibitor

    I and L Biosystems at European Antibody Congress

    Exhibitor

    Aldevron at European Antibody Congress

    Exhibitor

    BioRad at European Antibody Congress
  • Exhibitor

    Bio-Techne at European Antibody Congress

    Exhibitor

    DiscoverX Corporation Ltd at European Antibody Congress

    Exhibitor

    Groupe NOVASEP at European Antibody Congress
 

European Antibody CongressEuropean Antibody CongressEuropean Antibody CongressEuropean Antibody CongressEuropean Antibody CongressEuropean Antibody Congress
European Antibody CongressEuropean Antibody CongressEuropean Antibody CongressEuropean Antibody Congress

Testimonials

 

Pierre Fabre

"The EAC, managed by a very professional team, is a unique meeting that brings the entire mAbs stakeholder together with excellent speakers and sufficient time for networking.

Alain Beck 
Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Sanofi

Good science, wide industrial and academic representation, great organization! ” 

Alexey Rak
Head of Biostructure and Biophysics
Sanofi

Uiversity Hospital Basel

"Great meeting, top speaker, perfect location, accomodation and catering "  

Frank Stenner 
Oncologist,  University Hospital Basel

Cancer Research UK Cambridge Institut

“Great depth and variety with engaging open discussions across industry/academic and biotech ” 

Sidath Katugampola
Biomarker Development Specialist
Cancer Research UK Cambridge Institute  

Sign Up for Event Updates